USPTO issues trademark 'MCH-CAL' to Pharmazen for multiple goods including pet foods for medicinal purposes
Nevin Barich
ALEXANDRIA, Virginia
,
November 18, 2013
(U.S. Fed News)
–
The trademark MCH-CAL (Reg. No. 4431137) was issued on Nov. 12 by the USPTO.
Owner: Pharmazen Limited LIMITED LIABILITY COMPANY NEW ZEALAND Unit 5, 13 Desi Place Hillsborough Christchurch 8022 NEW ZEALAND.
The trademark application serial number 85730955 was filed on Sept. 17, 2012 and was registered on Nov. 12.
Goods and Services: Dietary supplements for humans and animals for medicinal purposes; pharmaceutical preparations for assisting the prevention of bone diseases; pharmaceutical preparations to treat peri-menopausal and post-menopausal conditions and for the prevention and treatment of osteoporosis, and pharmaceutical preparations to treat peri-menopausal and post-menopausal conditions and for the prevention and treatment of osteoporosis in powder form for use as ingredients in tablets, capsules, fortified beverages and pet foods for medicinal purposes; protein-based dietary supplements for humans made of bovine products and protein-based dietary supplements for humans made of bovine products in powder form for use as ingredients in tablets, capsules, fortified beverages and pet foods for medicinal purposes; all the foregoing goods contain calcium
Printed material, namely, product data sheets, brochures, and point of sale information pamphlets in the fields of food preparations adapted for medicinal purposes, dietary supplements for humans and animals, pharmaceutical preparations for assisting the prevention of bone diseases, pharmaceutical preparations to treat peri-menopausal and post-menopausal conditions and for the prevention and treatment of osteoporosis, bovine products for use as dietary supplements for humans and animals for medicinal and non-medicinal purposes
For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com
(c) 2013 US Fed News (HT Syndication)
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.